PRDM2 and cervical carcinoma: Reduced expression of RIZ1 and DAPK1 due to promoter hypermethylation has been reported in other malignancies as well, such as cervical cancer/ cervical neoplasia [43, 44], thyroid tumorigenesis [45], stomach carcinogenesis [46], cervical cancer [43], lung cancer patients[47–49].